American Society of Clinical Oncology plenary

Highlights from the University of Chicago Medicine Comprehensive Cancer Center at ASCO 2013

The University of Chicago Medicine Comprehensive Cancer Center had a strong presence at the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting held from May 31st to June 4th in Chicago.

The meeting brought together more than 25,000 oncology professionals from a broad range of specialties. This year’s theme was “Building Bridges to Conquer Cancer.”

The following UCCCC members participated in the meeting:

Ezra Cohen, MD, associate professor of medicine, was a discussant at the plenary session. He discussed the abstract, “Sorafenib in Locally Advanced or
Metastatic Patients with Radioactive Iodine-Refractory Differentiated Thyroid Cancer: The Phase III DECISION Trial.”

He also presented the abstract, “Long-Term Disease Control of Equal to or Greater Than 2 Years Achieved with Cabozantinib in Subjects with Metastatic
Medullary Thyroid Carcinoma on a Phase I Study.”

James Dignam, PhD, associate professor of health studies, was a co-author of a paper selected as one of the ASCO highlights that were presented at the plenary session. The abstract was “RTOG 0825: Phase III Double-Blind Placebo-Controlled Trial Evaluating Bevacizumab in Patients with Newly Diagnosed Glioblastoma.”

Tanguy Seiwert, MD, assistant professor of medicine, delivered a talk, “Phosphatidylinositide 3 Kinase Pathway Biology and Inhibitors” at the Molecular Pathways in Head and Neck Cancer session.

Everett Vokes, MD, John E. Ultmann Professor of Medicine, spoke at the Management of Oropharynx Cancer in the HPV Era: Intensify or De-Intensify session about “Intensifying Induction Chemotherapy as a Strategy to Improve Outcome in Human Papillomavirus-Positive Disease.”

John Cunningham, MBBCh, MSc, professor of pediatrics, spoke at the educational session, “Immunotherapy for Childhood Cancer: What the Practicing Oncologist Needs to Know.”

Hedy Kindler, MD, associate professor of medicine, presented a lecture, “Peritoneal Mesothelioma: It’s a Different Disease in the Abdomen,” at the Rare but Real: Management of Small Bowel Cancer, Peritoneal Mesothelioma, and Cancer of Unknown Primary session. She also participated as a discussant for “Challenges and Successes in Advanced Pancreatic Cancer.”

Blase Polite, MD, MPH, assistant professor of medicine, chaired a session, “Racial and Ethnic Disparities in Colorectal Cancer: Identifying the Problem and Finding Solutions.”

Kerstin Stenson, MD, professor of surgery, served on the Head and Neck Cancer Tumor Board.

Mark J. Ratain, MD, Leon O. Jacobson Professor of Medicine, was a discussant for “Clinical Trial Design for Older Cancer Patients” at the Staying Sage with Age session. He also presented a poster for “Frequent LOH of CYP2D6 in ER+ Breast Cancer Determined by Next-Generation Sequencing.”

At the Cancer Prevention/Epidemiology session:

Jane Churpek, MD, assistant professor of medicine, spoke on “Inherited Mutations in Breast Cancer Genes in African American Breast Cancer Patients Revealed by Targeted Genomic Capture and Next-Generation Sequencing.” She was also invited to speak at the ASCO press briefing.

Gini Fleming, MD, professor of medicine, was the co-chair for the Gynecologic Cancer session.

Tara Henderson, MD, MPH, assistant professor of pediatrics, was the chair for a Patient and Survivor Care session.

Richard Larson, MD, professor of medicine, presented the abstract, “Nilotinib Versus Imatinib in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase: ENESTnd 4-year Update.”

Sonia Kupfer MD, assistant professor of medicine, presented a poster for “Cancer Risks and Mutation Spectrum of Mismatch Repair Genes in African American Families with Lynch Syndrome.”

Hiroyuki Abe, MD, PhD, assistant professor of radiology, presented the abstract, “Recall Rate in a Semi-Annual Breast Surveillance Program for High-Risk Women.”

Jonas de Souza, MD, instructor of medicine, presented the abstract, “The Development of a Financial Toxicity Patient-Reported Outcome Instrument in Cancer.”

This story originally appeared in the June 2013 issue of Member News from the UCCCC.